Comparison · NCT03207776-ce316c8b
Intervention vs Control: Healthcare Utilization
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Intervention vs Control: Healthcare Utilization. Trial comparisons, record NCT03207776-ce316c8b. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03207776-ce316c8b
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.391 | 0.371 | 0.411 | wilson | |
| Risk in group 2 | 0.436 | 0.416 | 0.455 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0447 | -0.0723 | -0.0169 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.897 | 0.839 | 0.96 | log | |
| Odds ratio, group 1 over group 2 | 0.832 | 0.742 | 0.933 | log | |
| Number needed to treat, for one fewer participant with the outcome on Intervention than on Control | 22.4 | 13.8 | 59.2 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Intervention | A group of 4 Usual Care components that are applied consistently and completely amongst all patients who present with COPD acute exacerbation symptoms, plus access to navigator services (COPD Clinical Pathway).~COPD Clinical Pathway: A group of 4 Usual Care components that are applied consistently and completely amongst all patients who present with COPD acute exacerbation symptoms, plus access to navigator services. | 920 | 2,353 | OG001 |
| Group 2 | Control | Treatment of patients in the usual manner based on their diagnosis and resources available at that site (Usual Care).~Usual Care: Treatment of patients in the usual manner based on their diagnosis and resources available at that site. | 1,080 | 2,479 | OG000 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Healthcare Utilization
- Description
- Occurrence of Emergency Department, inpatient, or observation encounters after the initial encounter at accrual
- Time frame
- 60 days
- Population
Source ClinicalTrials.gov
Trial
- Title
- An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
- NCT number
- NCT03207776
- Phases
- NA
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Usual Care, COPD Clinical Pathway
- Lead sponsor
- Wake Forest University Health Sciences
- Results first posted
- 2019-10-14
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03207776?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03207776-ce316c8b